March 27 (Reuters) - Epigenomics AG ECXn.DE :
* FY TOTAL REVENUE OF EUR 1.5 MILLION AND EBITDA (BEFORE
SHARE-BASED PAYMENT EXPENSES) OF EUR -11.4 MILLION
* FY NET LOSS FOR YEAR TO EUR -12.7 MILLION (2017: EUR -10.2
MILLION).
* FOR 2019, WE EXPECT EBITDA BEFORE SHARE-BASED PAYMENT
EXPENSES
TO REMAIN UNCHANGED FROM PREVIOUS YEAR'S GUIDANCE IN A RANGE OF
EUR -11.5 MILLION TO EUR -14.0 MILLION.
* COMPANY EXPECTS REVENUE 2019 WITHIN RANGE OF EUR 3.0
MILLION TO
EUR 6.0 MILLION EVEN WITHOUT MEDICARE COVERAGE
Source text for Eikon: ID:nEQ1YqhHYa
Further company coverage: ECXn.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))